Longboard pharmaceuticals provides corporate update and reports third quarter 2021 financial results

San diego, nov. 04, 2021 (globe newswire) -- longboard pharmaceuticals, inc. (nasdaq: lbph), a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases, today provided a corporate update and reported financial results for the third quarter ended september 30, 2021.
LBPH Ratings Summary
LBPH Quant Ranking